Anti-IL6 drugs tocilizumab and sarilumab are known to be very effective in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, systemic, giant cell arteritis, and Cytokine Release Syndrome which occurs during therapy with Car-T. The gene discussed is IL6; the disease is juvenile idiopathic arthritis.